INTRODUCTION
The corpus callosum (CC) is one of the five main cerebral commissures connecting the left and right cerebral hemispheres. Corpus callosum abnormalities are separated into three categories: complete agenesis, partial agenesis, and dysgenesis (Palmer and Mowat, 2014) . The prevalence of agenesis of the corpus callosum (ACC) is around 1.4 per 10,000 live births (Glass et al., 2008) . ACC may be associated with intellectual disabilities, epilepsy, behavioral difficulties, and cognitive impairments (Moutard et al., 2003) . Many couples decide to terminate the pregnancy on the basis of ultrasound (US)/magnetic resonance imaging (MRI) findings in ACC. However, follow-up studies indicate that 71.2% of isolated ACC cases have normal intelligence, 13.6% have borderline or moderate intellectual disabilities, and 15.2% have severe intellectual disability (Santo et al., 2012) . These findings highlight the importance of improving the precision of the diagnosis of ACC as well as moving the window of diagnosis earlier in pregnancy.
Studies have shown that the majority of ACC cases are caused by de novo dominant mutations (De Ligt et al., 2012) . The Netrin receptor DCC (Deleted in colorectal cancer) gene is a critical factor in corpus callosum development in mice and works through orienting callosal axons at the midline (Fazeli et al., 1997) . DCC mutations have been shown to cause isolated ACC, including the reported mirror movement (MM) phenotype, in humans (Marsh et al., 2017) . Additionally, studies have shown that fibroblast growth factor receptor/glial fibrillary acidic protein (Fgfr1/Gfap) play an important role in corpus callosum formation (Smith et al., 2006) . Recently, whole-exon sequencing has provided the opportunity for molecular genetic screening of rare human diseases.
In the present study, we performed whole-exome sequencing in two families who had children who were affected by complete ACC. With whole-exon sequencing and Sanger sequencing, we identified two single-nucleotide missense mutations which are likely related to the pathogenesis of ACC.
CLINICAL REpORT proband 1
A fetal ultrasound of a 21-year-old G1P0 female at 26 weeks gestation revealed agenesis of the corpus collosum and a right lateral ventricle about 1.0 cm in width. A subsequent brain MRI performed at 28 weeks and 5 days gestation, determined by last menstrual period (LMP), confirmed complete callosal agenesis and showed mild ventriculomegaly. Both lateral ventricles had a width of approximately 11 mm, were parallel, and teardropshaped. The third ventricle was slightly widened and uplifted. No obvious corpus callosum signals were observed in each section. The cisterna magna was about 9 mm in width, and the vermis cerebelli was present (Figures 1A-C) . A female fetus was delivered at 31 weeks. There is no anatomic pathology data for the fetus.
proband 2
A 33-year-old G1P0 female presented at 26 weeks gestation for a fetal ultrasound which demonstrated agenesis of the corpus callosum. A subsequent brain MRI performed at 27 weeks, determined by LMP, confirmed complete callosal agenesis complicated by variant Dandy-Walker malformation. Specifically, the posterior horn was about 0.6 cm in width, the bilateral lateral ventricles were parallel, and the third ventricle was widened and uplifted. There was no obvious corpus callosum in each section. The posterior cranial fossa was about 0.8 cm in width and the fourth ventricle was about 0.9 cm in width. The superior vermis was present while the lower vermis was absent (Figures 1D-F) . The male fetus was delivered at 27 weeks, 5 days gestation. There is no anatomic pathology data for the fetus.
Chromosomal array (CMA) result of both the probands using CytoScan™ HD whole-genome SNP array (Affymetrix, USA) showed no disease-related copy number variations (CNVs). The reporting threshold of the copy number result was set at 500 kb with marker count ≥50 for gains and 200 kb with marker count ≥50 for losses.
MATERIALS AND METHODS

Ethics Approval for the Investigation
The Ethics Committee of the Women's Hospital, Zhejiang University, School of Medicine (Hangzhou, China) approved our study. The investigation conforms to the principles outlined in the Helsinki Declaration. Written informed consent was obtained from the patients and their spouses whose child's tissue was collected.
DNA Extraction
A 5-ml aliquot of peripheral whole blood was collected from the parents and EDTA was added for anticoagulation. Additionally, a 1 × 1 × 1-cm medial thigh muscle sample was gathered from the induced fetus. Genomic DNA from 2 ml of peripheral whole blood was extracted using a Qiagen Blood DNA mini kit (Qiagen ® , Hilden, Germany). DNA from muscle was extracted with a Genomic DNA Purification Kit (Invitrogen, cat. K0512, USA) and then preserved at -20°C. The remaining samples were stored at -80°C.
Whole-Exome Sequencing and Data Analysis
Target enrichment of target region sequences was carried out by the Agilent SureSelect Human Exon Sequence Capture Kit. The sequencing libraries were quantified using the Illumina DNA Standards and Primer Premix Kit (Kapa Biosystems, Boston, MA, USA), massively parallel sequenced using the Illumina HiSeq 2500 platform (Illumina, San Diego, CA, USA), and then massively parallel sequenced again using the Illumina HiSeq 2500 platform (Illumina, San Diego, CA, USA). After sequencing and filtering out low-quality reads, high-quality reads were compared to the human genome reference sequence (GRCh37.p12, hg19). The GATK software was used to call variants. 
RESULTS
Identification of Variants on Two probands
In proband 1, with the average coverage of 132.28X on targeted regions, we confirmed 95,687 novel genetic variants (GVs) through whole-exome sequencing (WES), while for proband 2, under mean coverage of 71.63X, we identified 79,974 GVs. The summary of WES for the two probands is shown in Table 1 .
pathogenic Mutations on Two probands
In proband 1, we identified 23 SNPs in callosum agenesisrelated genes compared to 11 SNPs identified in proband 2. Two pathogenic mutations were identified: chrX: 70349584: T:C (c.3746T>C) in exon 25 (Figure 2A ) and chrX: 68049752: G:C (c.128+5G>C) in intron 1 ( Figure 2C) ; These two mutations were further confirmed by Sanger sequencing (Figures 2B, D) .
MED12: c.3746T>C of proband 1 was inherited from his healthy mother ( Figure 2B ), while EFNB1: c.128+5G>C of proband 2 appeared de novo ( Figure 2D ). The T-to-C transversion at position 3746 resulted in a leucineto-proline substitution at code1249 in the mediator complex subunit12 (MED12) protein (p. L1249P) (Figure 3) , a gene which is highly conserved between different species. However, the missense mutation of EFNB1 located in intron 1 did not result in amino acid transversion; however, it was located 5 bp behind exon 1 of EFNB1. The HSF database strongly supports the pathogenicity of EFNB1: c.128+5G>C, indicating it might influence the RNA splicing.
DISCUSSION
In this report, we described two families whose fetuses were diagnosed with complete agenesis of the corpus callosum. With whole-exon sequencing, we identified one hemizygous missense mutation in exon 27 of MED12 on the X chromosome and one de novo heterozygous missense mutation in intron 1 of EFNB1 on the X chromosome.
Currently, fetal MRI and ultrasound are useful tools in the diagnosis of complete ACC (cACC) in second-and thirdtrimester pregnancies (Tang et al., 2009) . Genetic diagnosis with whole-exon sequencing offers the potential for an earlier diagnosis of cACC accompanied by the option for earlier termination of pregnancy. Though autosomal-dominant, autosomal-recessive, and X-linked patterns have been described as causes of ACC (Edwards et al., 2014) , there has been no clear inheritance model found in the majority of cases, Therefore, it is likely that most cases arise from a de novo mutation. Some cases of partial ACC (OMIM, 304100) follow an X-linked recessive pattern caused by a mutation in the L1 cell adhesion molecule (L1CAM) gene on chromosome Xq28, which only affects male fetus. Additionally, Bassuk and Sherr reported a de novo mutation c.427T>G (S143A) of gene PRICKLE1 in fetal agenesis of the corpus callosum without other possible mutations (Bassuk and Sherr, 2015) .
In our study, we identified another X-linked recessive mutation in the MED12 gene associated with cACC. MED12 encodes one of the subunits of the Mediator complex, and MED12 has a role in RNA polymerase II transcription (Donnio et al., 2017) . Hong et al. showed that med12-deficient zebrafish embryos showed defects in brain, neural crest, and kidney development (Hong et al., 2005 (Schwartz et al., 2007; Prontera et al., 2016) .While these syndromes are caused by mutations along different positions of the MED12 gene, they may be related with a deficient or absent corpus (Graham and Schwartz, 2013) . The EFNB1 mutation in our study follows an X-linked dominant inheritance pattern and has been mostly described in patients with craniofrontonasal syndrome (CFNS; OMIM 304110) (Wallis et al., 2008; Hogue et al., 2010) . Features of the disease include frontonasal dysplasia, craniofacial asymmetry, craniosynostosis, bifid nasal tip, grooved nails, and abnormalities of the thoracic skeleton. It has been shown that EFNB1 plays an important role in defining the position of the coronal suture (Twigg et al., 2004 ). Yet, to our knowledge, these two mutations have not been reported in literature. Our study expended the clinical spectrum of abnormalities associated with mutations in the X chromosome in humans. Since both of these two mutations are located in chromosome X, we inferred that male fetuses are more likely to develop complete agenesis of the corpus callosum. This finding is in accordance with a previous large cohort study on patients with agenesis of the corpus callosum that showed a slightly increased prevalence in males (56% vs. 44%) (Romaniello et al., 2017 ). Since we collected samples from the expired fetuses in utero, there is no information regarding the intellectual function of these probands. Therefore, it was difficult to connect the mutation identified closely to intellectual disabilities, epilepsy, behavioral difficulties, or cognitive impairments in childhood or adulthood. In future studies, we are planning to carry out a large cohort analysis of agenesis of the corpus callosum with these mutations to further confirm our results and establish a scientific significance for genotype-phenotype correlation.
CONCLUSION
Fast development of high-throughput sequencing provides our clinicians with a new pathway to explore the potential for genetic diagnosis of fetal ACC. Whole exon sequencing combined with Sanger sequencing demonstrated mutations of MED12 and EFNB1 associated with cACC and strongly implicates these two genes as one causative explanation for fetal cACC.
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